Brighton Jones LLC Invitae Corp Transaction History

Brighton Jones LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$0.6 - $1.53 $23,669 - $60,356	-39,449 Reduced 70.09%	16,831 $10,000
Q2 2023 Jul 31, 2023	BUY	$1.05 - $1.63 $13,310 - $20,663	12,677 Added 29.07%	56,280 $63,000
Q1 2023 May 08, 2023	SELL	$1.2 - $2.73 $1,287 - $2,929	-1,073 Reduced 2.4%	43,603 $58,000
Q4 2022 Feb 02, 2023	BUY	$1.71 - $3.61 $13,835 - $29,208	8,091 Added 22.12%	44,676 $83,000
Q3 2022 Nov 09, 2022	BUY	$1.9 - $8.63 $2,038 - $9,259	1,073 Added 3.02%	36,585 $90,000
Q2 2022 Aug 04, 2022	BUY	$2.13 - $9.01 $4,411 - $18,659	2,071 Added 6.19%	35,512 $87,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $728 - $1,808	116 Added 0.35%	33,441 $267,000
Q4 2021 Feb 03, 2022	BUY	$14.7 - $28.67 $213,135 - $415,686	14,499 Added 77.02%	33,325 $509,000
Q3 2021 Nov 04, 2021	BUY	$24.31 - $33.6 $2,503 - $3,460	103 Added 0.55%	18,826 $535,000
Q2 2021 Aug 10, 2021	BUY	$26.09 - $40.4 $54,841 - $84,920	2,102 Added 12.65%	18,723 $632,000
Q1 2021 May 07, 2021	SELL	$33.06 - $56.93 $1,653 - $2,846	-50 Reduced 0.3%	16,621 $635,000
Q4 2020 Feb 10, 2021	BUY	$39.09 - $57.4 $651,669 - $956,915	16,671 New	16,671 $697,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.